1. Li, Wenlu, Shi, Jingfei, Yu, Zhanyang, Wainger, Brian J, Lo, Eng H. 2024. SLC22A17 as a Cell Death-Linked Regulator of Tight Junctions in Cerebral Ischemia. In Stroke, 55, 1650-1659. doi:10.1161/STROKEAHA.124.046736. https://pubmed.ncbi.nlm.nih.gov/38738428/
2. Liu, Yan, Shao, Yi-Hui, Zhang, Jun-Meng, Du, Jie, Li, Yu-Lin. 2023. Macrophage CARD9 mediates cardiac injury following myocardial infarction through regulation of lipocalin 2 expression. In Signal transduction and targeted therapy, 8, 394. doi:10.1038/s41392-023-01635-w. https://pubmed.ncbi.nlm.nih.gov/37828006/
3. Lavoro, Alessandro, Falzone, Luca, Gattuso, Giuseppe, Libra, Massimo, Candido, Saverio. 2024. Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma. In Journal of translational medicine, 22, 887. doi:10.1186/s12967-024-05622-9. https://pubmed.ncbi.nlm.nih.gov/39358721/
4. Wei, Jianming, Gao, Xibo, Qin, Yulan, Liu, Tong, Kang, Yani. 2020. An Iron Metabolism-Related SLC22A17 for the Prognostic Value of Gastric Cancer. In OncoTargets and therapy, 13, 12763-12775. doi:10.2147/OTT.S287811. https://pubmed.ncbi.nlm.nih.gov/33363382/